Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19. | Curr Pharm Des;28(22): 1779, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19.

Hu, Tao; Cho, Chi Hin.

Hu T; Evergreen Therapeutics, Inc. Bethesda, MD 20817, USA.
Cho CH; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Curr Pharm Des ; 28(22): 1779, 2022.

Article in English | MEDLINE | ID: covidwho-2022254

Subject(s)

COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Interleukin-6; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokine Release Syndrome / COVID-19 Limits: Humans Language: English Journal: Curr Pharm Des Journal subject: Pharmacy Year: 2022 Document Type: Article Affiliation country: 138161282822220721121211

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokine Release Syndrome / COVID-19 Limits: Humans Language: English Journal: Curr Pharm Des Journal subject: Pharmacy Year: 2022 Document Type: Article Affiliation country: 138161282822220721121211